𝐈𝐦𝐚𝐠𝐢𝐧𝐞 𝐭𝐡𝐢𝐬:
A patient in Spain misreads dosage instructions from a poorly translated leaflet.
The brand had passed all QA checks except accessibility.

𝐈𝐭’𝐬 𝐧𝐨𝐭 𝐫𝐚𝐫𝐞.
According to the European Medicines Agency (EMA), over 30% of product recalls in multilingual markets link back to translation or readability failures in patient materials.
#PharmaLocalization #PatientSafety #LifeSciencesTranslation #Accessibility #MedicalQA #RegulatoryCompliance